mygmptraining

This episode of the Deep Dive podcast navigates the complex regulatory and engineering landscape of pharmaceutical water systems , using the FDA’s July 1993 Inspection Guide as a foundational roadmap. WFI (Water for Injection): Required for parenteral (injectable) drugs, WFI must be free of pyrogens , specifically endotoxins —the structural remnants of dead gram-negative bacteria that can cause se...

This presentation outlines the regulatory requirements for pharmaceutical organization and personnel as defined by 21 CFR Part 211, Subpart B . It emphasizes the critical role of the Quality Control Unit , which possesses the authority to approve or reject all materials and procedures impacting product integrity. The materials specify that staff and consultants must be qualified through a blend of...

This episode outlines official FDA guidance regarding the specific behaviors that constitute the obstruction of drug or device inspections . Under federal law, if a facility delays, denies, limits, or refuses an inspection, the products manufactured there are legally considered adulterated . Prohibited actions include failing to schedule pre-announced visits, withholding records , and restricting...

This podcast outlines the essential standards for process validation within the pharmaceutical and biologics industries. It establishes a three-stage lifecycle approach that includes process design , process qualification , and continued process verification to ensure drug quality and consistency. The discussion emphasizes using scientific evidence and risk-based analysis to maintain manufacturing...

This episode talks about the FDA-mandated guidance document for managing out-of-specification (OOS) results within the pharmaceutical industry. The guidance emphasizes a rigorous two-phase investigation to determine if a failure stems from a laboratory error or a deeper manufacturing flaw . Phase I focuses on the analyst’s immediate assessment of technical accuracy, while Phase II involves a full-...